1
Introduction
Learning Objectives
Etiology and Transmission
Pathogenesis and Clinical Manifestations
BCG Vaccine
Risk of Infection
Progression of Tuberculosis Infection to Disease
Drug-Resistant Tuberculosis
Summary Module 1
Etiology and Pathogenesis of Tuberculosis
Main Menu
MODULE 0 - Introduction
MODULE 1 - Etiology and Pathogenesis of Tuberculosis
MODULE 2 - Diagnosis of Tuberculosis
MODULE 3 - Treatment of Patients with Tuberculosis Introduction
MODULE 4 - Special Situations
MODULE 5 - Adherence to Treatment
MODULE 6 - Patient-Physician Communication
MODULE 7 - Tuberculosis Infection Control
1.5
BCG Vaccine
a
BCG (Bacille Calmette-Guerin) is a live attenuated vaccine derived originally from M. bovis, a closely related organism to
M. tuberculosis.
The route of injection is intradermal.
The usual dose is 0.05 ml in neonates and infants under the age of 3 months, and 0.1 ml in older children.
